| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 296,622 | 277,797 | 304,966 | 257,727 | | Cost of Revenue | 226,584 | 219,995 | 249,935 | 233,949 | | | Gross Profit | 70,038 | 57,802 | 55,031 | 23,778 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,351 | 8,670 | 10,611 | 11,096 | | Non Recurring |
-
| (3,108) | (78) | 37,585 | | Others | 26,996 | 26,035 | 26,263 | 25,169 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 37,689 | 26,205 | 18,235 | (50,072) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2) | 3,108 | 78 |
-
| | Earnings Before Interest And Taxes | 24,280 | 12,991 | 5,217 | (50,072) | | Interest Expense |
-
| 13,214 | 13,018 | 12,088 | | Income Before Tax | 24,280 | 12,991 | 5,217 | (62,160) | | Income Tax Expense | 5,566 | 2,613 | 1,495 | (25,207) | | Minority Interest | 2 | 4 | (29) | 3 | | | | Net Income From Continuing Ops | 18,716 | 10,382 | 3,693 | (36,950) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,716 | 10,382 | 3,693 | (36,950) | | Preferred Stock And Other Adjustments |
-
| 4 | (29) |
-
| | | Net Income Applicable To Common Shares | $18,716 | $10,382 | $3,693 | ($36,950) |
|
0.51% Nasdaq 
Income Statement
